Molecular-weight-dependent, anionic-substrate-preferential transport of β-lactam antibiotics via multidrug

Shin-Ichi Akanuma1, Yasuo Uchida, Sumio Ohtsuki

  • 1Division of Membrane Transport and Drug Targeting, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.

Insights

Multidrug resistance-associated protein 4 (MRP4) transports beta-lactam antibiotics, influencing their brain distribution. This study quantifies transport activity, revealing cephalosporins are most affected, aiding understanding of adverse drug effects.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Drug Metabolism

Background:

  • Beta-lactam antibiotics can cause cerebral and peripheral adverse effects.
  • Multidrug resistance-associated protein 4 (MRP4) is implicated in transporting beta-lactam antibiotics and limiting their brain entry via the blood-brain barrier.

Purpose of the Study:

  • To elucidate the structure-activity relationship of MRP4-mediated transport for various beta-lactam antibiotics.
  • To quantify the transport activity of MRP4 for different classes of beta-lactam antibiotics.

Main Methods:

  • Utilized MRP4-expressing Sf9 membrane vesicles to assess transport activity.
  • Quantified MRP4 protein expression using liquid chromatography-tandem mass spectrometry.
  • Evaluated transport activity as MRP4-mediated transport per MRP4 protein (nL/min·fmol).

Main Results:

  • Cefotiam exhibited the highest MRP4-mediated transport activity (8.90 nL/min·fmol).
  • Cephalosporins showed greater MRP4 transport than penams, beta-lactamase inhibitors, penems, or monobactams.
  • Anionic cephalosporins and higher-molecular-weight anionic beta-lactams were transported more efficiently by MRP4 than their zwitterionic or lower-molecular-weight counterparts.

Conclusions:

  • Quantitative data on MRP4 transport of beta-lactam antibiotics provide insights into structure-activity relationships.
  • Findings aid in understanding MRP4-related adverse effects of beta-lactam antibiotics and their derivatives.
  • Differential transport kinetics highlight the influence of chemical properties on MRP4 interaction.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Pore Transport and Ion-Pair Transport01:17

Pore Transport and Ion-Pair Transport

Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited  but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...